DE358739T1 - Monoklonale antikoerper gegen glykosyliertes albumin, hybride zellinien, die diese antikoerper produzieren, sowie deren verwendung.
- Google Patents
Monoklonale antikoerper gegen glykosyliertes albumin, hybride zellinien, die diese antikoerper produzieren, sowie deren verwendung.
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
EXOCELL Inc PHILADELPHIA PA US
Original Assignee
EXOCELL Inc PHILADELPHIA PA US
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/147,363external-prioritypatent/US5223392A/en
Application filed by EXOCELL Inc PHILADELPHIA PA USfiledCriticalEXOCELL Inc PHILADELPHIA PA US
Publication of DE358739T1publicationCriticalpatent/DE358739T1/de
DE19899024881988-01-251988-12-15Monoklonale antikoerper gegen glykosyliertes albumin, hybride zellinien, die diese antikoerper produzieren, sowie deren verwendung.
PendingDE358739T1
(de)
Einen monoklonalen antikoerper gegen kupfer-zink-superoxiddismutase enthaltendes arzneimittel fuer diagnostischen test und dasselbe verwendendes diagnostisches testverfahren.